The submitted project is about models for the development of new therapeutic options for cancer treatment. Every two years, the association Ärzte gegen Tierversuche e.V. (Doctors Against Animal Experi
$60M program focusing on Dynamic Resilience from Wellcome Leap and Temasek Trust funds international research group led by Tübingen professor Dynamic resilience, the ability of humans to withstand une
More than seven million people in Germany suffer from diabetes. Drug research is still difficult. Scientists led by Peter Loskill from the NMI and the University of Tübingen have developed a technique
Does our therapeutic approach work against cancer? A planned NMI spin-off has developed a technology that shall answer this question more quickly - and thus save valuable time for patients and money f
Heal-X Bioink: The new chapter in 3D bioprinting begins! Today saw the much-anticipated kick-off of the BMBF-funded Heal-X Bioink project, which focuses on the development of a self-healing, bio-inspi
Dr. Teresa Wagner receives the PI Innovation Award for groundbreaking cancer research that leads to a spin-out activity at the NMI The newly introduced PI Innovation Award for outstanding research at
The EUROoCS Conference 2024 in Milan is over and the µOrganoLab team is delighted with its great success. The EUROoCS Academy organized by the 3R-Center Tübingen and the EUROoCS working group "Teachin
What opportunities does quantum technology open up for the healthcare sector? The matchmaking event “Quantum Technologies & Photonics meet Medtech” at the NMI today focused on precisely these opportun
20 years ago she won the Klee Prize, today she inspired as a keynote speaker: Prof. Dr. Katja Schenke-Layland at the BMT 58th DGBMT Annual Conference in Stuttgart. A special moment: Prof. Dr. Katja Sc
Yesterday (October 16, 2024), NMI employee Dr. Nicole Anderle was awarded the Reinhold-und-Maria Teufel Foundation Prize for her doctorate on precision oncology. The prize is endowed with 5,000 euros
